Delineating melanoma using multimodal polarized light imaging

Lasers in Surgery and Medicine

Volumn 41, Issue 1, 2009, Pages 10-16

  Tannous, Zeina ^a,b   Al Arashi, Munir ^b   Shah, Sonali ^a,c   Yaroslavsky, Anna N ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Fluorescence; Melanoma; Methylene blue; Polarization imaging; Reflectance; Tetracycline

Indexed keywords

METHYLENE BLUE; TETRACYCLINE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; FLUORESCENCE; FLUORESCENCE POLARIZATION; HISTOPATHOLOGY; HUMAN; IMAGING; MALE; MELANOMA; PRIORITY JOURNAL; SKIN DEFECT;

ADULT; AGED; AGED, 80 AND OVER; CHROMOGENIC COMPOUNDS; DYSPLASTIC NEVUS SYNDROME; FLUORESCENCE POLARIZATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LASERS; MALE; MELANOMA; METHYLENE BLUE; MICROSCOPY, POLARIZATION; MIDDLE AGED; PILOT PROJECTS; SKIN NEOPLASMS; TETRACYCLINE;

EID: 58449098981     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20736     Document Type: Article

References (19)

1. World Health Organization, GLOBOCAN: Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancerbase No. 5, Version 1.0. Lyon: IARC 2001.
2. Yaroslavsky AN, Neel V, Anderson RR. Demarcation of nonmelanoma skin cancer margins using multi-spectral polarized-light imaging. J Invest Dermatol 2003;121:259-266.
3. Yaroslavsky AN, Neel V, Anderson RR. Fluoresence polarization imaging for deliniating nonmelanoma skin cancers. Opt Lett 2004;29:2010-2012.
4. Bickel WS, Davidson JF, Huffman DR, Kilkson R. Application of polarization effects in light scattering: A new biophysical tool. Proc Natl Acad Sci USA 1976;73:486-490.
5. Backman V, Wallace MB, Perelman LT, et al. Detection of preinvasive cancer cells. Nature 2000;406:35-36.
6. Jacques SL, Roman JR, Lee K. Imaging superficial tissues with polarized light. Lasers Surg Med 2000;26:119-129.
7. McLeary JR. The use of systemic tetracyclines and ultraviolet in cancer detection. Am J Surg 1958;96:415.
8. 99mTc-tetracycline. Radiology 1974;112:147-153.
9. Davis RC, Wood P, Mendelsohn ML. Localization and therapeutic potential of tritiated tetracycline in rodent tumors. Cancer Res 1977;37:4539-4545.
10. Olmedo-Garcia N, Lopez-Prats F. Tetracycline fluorescence for the preoperative localization of osteoid osteoma of the triquetrum. Acta Othopaedica Belgica 2002;68:306-309.
11. Yaroslavsky AN, Salomatina EV, Neel V, Anderson R, Flotte T. Fluorescence polarization of tetracycline derivatives as a technique for mapping nonmelanoma skin cancers. J Biomed Opt 2007;12(1):014005.
12. Gill WB, Huffman JL, Lyon ES, Bagley DH, Schoenberg HW, Straus FH. Selective surface staining of bladder tumors by intravesical Methylene Blue with enhanced endoscopic identification. Cancer 1984;53:2724-2727.
13. Kaisary AV. Assessment of radiotherapy in invasive bladder carcinoma using in vivo methylene blue staining technique. Urology 1986;28(2):100-102.
14. Fukui I, Yokokawa M, Mitani G, et al. In vivo staining test with methylene blue for bladder cancer. J Urol 1983;130(2):252.
15. Fedorak IJ, Ko TC, Gordon D, Flisak M, Prinz RA. Localization of islet cell tumors of pancreas: A review of current techniques. Surgery 1993;113:242-249.
16. Canto MI, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV Jr. Methylene blue selectively stains metaplasia in Barrett's esophagus. Gastrointest Endosc 1996;44(1):1-7.
17. Eisen GM, Montgomery EA, Azumi N, Hatmann D-P, Bhargava P, Lippman M, Benjamin SB. Qualitative mapping of Barrett's metaplasia: A prerequisite for intervention trials. Gastrointest Endosc 1999;50(6):814-818.
18. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: Treatment of cutaneous tumors and lymph node metastases cancer research. 1992;52:4385-4390.
19. Varghese P, Abdel-Rahman AT, Akberali S, Mostafa A, Gattuso JM, Carpenter R. Methylene blue dye - A safe and effective alternative for sentinel lymph node localization. Breast J 2008;14(1):61-67.